The Incidental Resolution of Severe Alcohol Use Disorder during Esketamine Treatment of Major Depressive Disorder: A Case Report
Alcohol use disorder (AUD) is especially prevalent among individuals with major depressive disorder (MDD) and is associated with higher morbidity, mortality, disability, and risk for suicide. Intranasal esketamine has been documented to be a safe and effective option for treatment resistant MDD and...
Saved in:
| Main Authors: | Zeeshan Faruqui, Christopher Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Case Reports in Psychiatry |
| Online Access: | http://dx.doi.org/10.1155/2022/8992697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comorbidity of Major Depressive Disorder, Alcohol Use Disorder, and Anorexia Nervosa: A Rare Case Report
by: Ya-Lin Huang, et al.
Published: (2025-04-01) -
Effects of Binaural Beat Music and Esketamine for ECT in the Treatment of Major Depressive Disorder: A Randomized Controlled Trial Protocol
by: Zhang Y, et al.
Published: (2025-06-01) -
Esketamine Optimized the Efficacy of Dexmedetomidine in Treating Sleep Disorders with Comorbid Depression
by: Ding Y, et al.
Published: (2025-07-01) -
Safety Profile and Suicidality Associated with the Use of Esketamine in the Treatment of Major Depressive Disorder in European Countries: An EudraVigilance Database Analysis
by: Ilaria Ammendolia, et al.
Published: (2025-05-01) -
Early TMS—EEG responses predict symptom severity in major depressive disorder
by: Elena Ukharova, et al.
Published: (2025-01-01)